HTR1A and schizophrenia: In addition, ziprasidone also acts on 5HT1A receptor as the agonist in human brain tissue, which has been identified as a potential therapeutic target for the treatment of schizophrenia in previous studies (Bantick, Deakin, & Grasby, 2001; Millan, 2000).